Haemonetics Corp. (HAE) Sank To A New Low After Q4 Profit Fell Short

Haemonetics Corp. (HAE) reported fourth quarter EPS of $0.37 Monday morning, down from $0.47 last year. The consensus estimate was for EPS of $0.46.

from RTT - Before the Bell http://ift.tt/1SIZ6Ep
via IFTTT